Sergi Basco, Jordi Domènech, Joan R. Rosés: Unequal Mortality during the Spanish Flu, in The London School of Economics and Poltical Science, Economic History Department, Economic History Working Papers No. 325 (February 2021). The outburst of deaths and cases of Covid-19 around the world has renewed the interest to understand the mortality effects of pandemics across regions, occupations, age and gender. According to the authors the “Spanish Flu” is the closest pandemic to Covid-19.
mh
238 posts
Maciej Stefański: GDP Effects of Pandemics: A Historical Perspective, in: Collegium of Economic Analysis Working Paper Series, Working Paper 2020/057 (December 2020). The author estimates dynamic effects of pandemics on Gross Domestic Product (GDP) per capita with local projections, controlling for the effects of wars and weather conditions, using a novel dataset that covers 33 countries and stretches back to the 13th century.
Enrico Berkes, Olivier Deschenes, Ruben Gaetani, Jeffrey Lin, Christopher Severen: Lockdowns and Innovation: Evidence from the 1918 Flu Pandemic, in: NBER Working Paper Series, Working Paper 28152 (November 2020), DOI: 10.3386/w28152. In their article, the authors address the question of whether social distancing harms innovation. They provide an assessment of the effect of non-pharmaceutical interventions (NPIs) on local inventions.
Robert J. Barro, José F. Ursua, Joanna Weng: The Coronavirus and the Great Influenza Epidemic. Lessons from the “Spanish Flu” for the Coronavirus’s Potential Effects on Mortality and Economic Activity, in: NBER Working Paper Series, Working Paper 26866, March/April 2020. According to the authors of this paper, mortality and economic contraction during the 1918-1920 Great Influenza Pandemic provide plausible upper bounds for outcomes under the coronavirus (COVID-19).
Ricardo F. Savaris, Guilherme Pumi, Jovani Dalzochio, Rafael Kunst: Stay-at-home policy is a case of exception fallacy: an internet-based ecological study, in: Scientific Reports 11 (2021) Article 5313, DOI: 10.1038/s41598-021-84092-1. A recent mathematical model has suggested that staying at home did not play a dominant role in reducing COVID‑19 transmission. The second wave of cases in Europe, in regions that were considered as COVID‑19 controlled, may raise some concerns. The authors objective was to assess the association between staying at home (%) and the reduction/increase in the number of deaths due to COVID‑19 in several regions in the world.
Paul R. Hunter, Felipe J. Colón-González, Julii Brainard, Steven Rushton: Impact of non-pharmaceutical interventions against COVID-19 in Europe: A quasi-experimental study, in: medRxiv, July 2020, doi: https://doi.org/10.1101/2020.05.01.20088260. The current COVID-19 epidemic is unparalleled in recent history as are the social distancing interventions that have led to a significant halt on the economic and social life of so many countries. However, there is very little empirical evidence about which social distancing measures have the most impact. The authors report a quasi-experimental study of the impact of various interventions for control of the outbreak.
Charles A. E. Goodhart, Donato Masciandaro, Stefano Ugolini: Pandemic recession, helicopter money and central banking: Venice, 1630, in: CEPR discussion paper series, Discussion Paper No. 15715, London, January 2021. This paper analyses the monetary policy that the Most Serene Republic of Venice implemented in the years of calamities using a modern equivalent of helicopter money, precisely an extraordinary money issuing, coupled with capital losses for the issuer.
Jan M. Brauner et al: Inferring the effectiveness of government interventions against Covid-19, in Science 371 (February 2021) no. 6531, pp. 1-8, DOI: 10.1126/science.abd9338. Governments are attempting to control the COVID-19 pandemic with nonpharmaceutical interventions (NPIs). However, the effectiveness of various NPIs at reducing transmission is poorly understood. The authors collected chronological data on the implementation of NPIs for several European and non-European countries between January and the end of May 2020.
Philipp Ager, Katherine Eriksson, Ezra Karger, Peter Nencka, Melissa A. Thomasson: School Closures During the 1918 Flu Pandemic, in: NBER Working Paper Series, Working Paper No. 28246 (December 2020), DOI: 10.3386/w28246. The Covid 19 pandemic has reignited interest in responses to the 1918/19 influenza pandemic, the last comparable public health emergency in the United States. During both pandemics, many state and local governments made the controversial decision to close schools. The authors studied the short- and long-term effects of 1918-19 pandemic-related school closures on children.
Marco Del Angel, Caroline Fohlin, Marc D. Weidenmier: Do Global Pandemics Matter for Stock Prices? Lessons from the 1918 Spanish Flu, in: NBER Working Paper Series, Working Paper 28356, January 2021, DOI: 10.3386/w28356. The authors examine the impact of the 1918 “Spanish” flu on stock prices in the United States.
Rabail Chaudhry, George Dranitsaris, Talha Mubashir, Justyna Bartoszko, Sheila Riazi: A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes, in: EClinicalMedicine 25 (2020) 100464, DOI: https://doi.org/10.1016/j.eclinm.2020.100464. The authors conducted a country-level exploratoy analysis to assess the impact of timing and nature of national health policies or actions taken on COVID-19 mortality and related health outcomes.
Oxfam Deutschland e.V. (Ed.): Das Ungleichheitsvirus. Wie die Corona-Pandemie soziale Ungleichheit verschärft und warum wir unsere Wirtschaft gerechter gestalten müssen (The Inequality Virus. How the Corona Pandemic Exacerbates Social Inequality and Why We Need to Make Our Economy Fairer), Berlin, January 2021. Ahead of the World Economic Forum, Oxfam publishes the report “The Inequality Virus.” The report shows how the Corona pandemic is exacerbating social inequality and why the solution lies in a just economic system.
Quentin De Larochelambert, Andy Marc, Juliana Antero, Eric Le Bourg, Jean-François Toussaint: Covid-19 Mortality: A Matter of Vulnerability Among Nations Facing Limited Margins of Adaptation, in: Frontiers in Public Health, Vol. 8, Artikel 604339, November 2020.
Matthias Schrappe, Hedwig François-Kettner, Matthias Gruhl, Dieter Hart, Franz Knieps, Philip Manow, Holger Pfaff, Klaus Püschel, Gerd Glaeske: Thesenpapier 7. Die Pandemie durch SARS-CoV-2/CoViD-19. Sorgfältige Integration der Impfung in eine umfassende Präventionsstrategie. Impfkampagne resilient gestalten und wissenschaftlich begleiten. Aufklärung und Selbstbestimmung beachten, thesis paper version 7, final version Cologne, Berlin, Bremen, Hamburg January 10, 2021. (Thesis Paper 7. The Pandemic by SARS-CoV-2/CoViD-19. Carefully Integrating Vaccination into a Comprehensive Prevention Strategy. Make vaccination campaign resilient and provide scientific support. Respect education and self-determination).
Andrew Atkeson, Karen Kopecky, Tao Zha: Four Stylized Facts about COVID-19, in: NBER Working Paper Series, Working Paper 27719 (August 2020), DOI 10.3386/w27719. The authors document four facts about the COVID-19 pandemic worldwide relevant for those studying the impact of non-pharmaceutical interventions (NPIs) on COVID-19 transmission.
Arznei-Telegramm: Neu auf dem Markt. Covid-19-Impfstoff von Moderna, in: arznei-telegramm, No. 52 (January 22, 2021), pp. 1-4. In this issue of arznei-telegramm, the authors deal with the Covid-19 vaccine from the company Moderna.
Arznei-Telegramm: Im Blickpunkt. Impfstoffe gegen Covid-19. Anlass zur Hoffnung oder unkalkulierbares Risiko?, in: arznei-telegramm Nr. 51 (18. Dezember 2020), pp. 89-92. (In Focus. Vaccines against Covid-19: Cause for hope or incalculable risk?). In the December issue of arznei-telegramm, the authors of this article discussed the hopes for an effective vaccine that could help contain the pandemic, and the risks that these fast-track vaccines could pose.
BUKO Pharma-Kampagne (ed.): Nutzen von Covid-19 Impfungen. Wissensstand noch unbefriedigend, in: Pharma-Brief 10, December 2020. (Benefits of Covid-19 vaccinations. State of knowledge still unsatisfactory.) In its article, BUKO Pharma-Kampagne addresses the issue of vaccines against the coronavirus. “Several vaccines against covid-19 are close to approval or have already received emergency approval. But what do we even know about benefits and risks? The media reports high vaccine efficacy of 90% or more. The reports suggest that this means preventing severe disease and interrupting transmission of Covid-19. This is a misunderstanding, probably triggered by the fact that the figures circulating were based […]
Thomas Wieland: A phenomenological approach to assessing the effectiveness of COVID-19 related nonpharmaceutical interventions in Germany, in: Safety Science, Volume 131, 2020.
World Bank Group (ed.): Poverty and Shared Prosperity 2020: Reversals of Fortune. Washington, DC: World Bank, 2020. The Poverty and Shared Prosperity series provides a global audience with the latest and most accurate estimates on trends in global poverty and shared prosperity. For more than two decades, extreme poverty was steadily declining. Now, for the first time in a generation, the quest to end poverty has suffered its worst setback.